Versant Venture Management, LLC Crispr Therapeutics Ag Transaction History

Versant Venture Management, LLC

$67.6 Million
Q4 2024

A detailed history of Versant Venture Management, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Versant Venture Management, LLC holds 498,558 shares of CRSP stock, worth $21.6 Million. This represents 29.01% of its overall portfolio holdings.

Number of Shares

498,558

Previous 498,558 -0.0%

Holding current value

$21.6 Million

Previous $23.4 Million 16.24%

% of portfolio

29.01%

Previous 61.4%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$110.2 - $156.64 $1.1 Million - $1.57 Million	-10,000 Reduced 1.97%	498,558 $55.8 Million
Q2 2021 Aug 12, 2021	SELL	$100.84 - $161.89 $106 Million - $169 Million	-1,046,402 Reduced 67.29%	508,558 $82.3 Million
Q1 2021 May 07, 2021	SELL	$110.72 - $210.04 $164 Million - $312 Million	-1,485,502 Reduced 48.86%	1,554,960 $189 Million
Q4 2020 Feb 16, 2021	SELL	$79.67 - $173.23 $47.1 Million - $102 Million	-591,194 Reduced 16.28%	3,040,462 $466 Million
Q3 2020 Nov 12, 2020	SELL	$78.5 - $100.64 $43.3 Million - $55.5 Million	-551,408 Reduced 13.18%	3,631,656 $304 Million
Q2 2020 Jul 20, 2020	SELL	$38.5 - $76.05 $868,213 - $1.72 Million	-22,551 Reduced 0.54%	4,183,064 $307 Billion
Q4 2019 Jan 21, 2020	SELL	$36.68 - $73.13 $1.04 Million - $2.07 Million	-28,255 Reduced 0.67%	4,205,615 $256 Billion
Q3 2019 Oct 08, 2019	SELL	$40.99 - $52.56 $615,587 - $789,346	-15,018 Reduced 0.35%	4,233,870 $174 Billion
Q1 2019 Apr 05, 2019	BUY	$28.02 - $40.87 $17.9 Million - $26.2 Million	640,014 Added 17.73%	4,248,888 $152 Billion
Q2 2018 Jul 13, 2018	SELL	$42.62 - $73.59 $42.5 Million - $73.4 Million	-997,368 Reduced 21.65%	3,608,874 $212 Billion
Q1 2018 May 03, 2018	BUY	$23.52 - $58.17 $108 Million - $268 Million	4,606,242 New	4,606,242 $211 Billion

Others Institutions Holding CRSP

# of Institutions

491

Shares Held

59.8M

Call Options Held

1.1M

Put Options Held

1.72M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.38B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Venture Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Versant Venture Management, LLC with notifications on news.

Account

Versant Venture Management, LLC Crispr Therapeutics Ag Transaction History